DIABETES RXD
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 01 Jun 2023)
What this means for you
Registered since 07 Nov 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Nov 2027: the §8 & §9 renewal).
Record
- Serial number
- 86561027
- Registration number
- 5330094
- Mark type
- Word mark
- Filed
- 11 Mar 2015
- Published for opposition
- 18 Aug 2015
- Registered
- 07 Nov 2017
- Next maintenance filing
- §8 & §9 renewal, due by 07 Nov 2027 (grace period to 07 May 2028)
- Attorney of record
- Eric P. Mirabel, JD, LLM
Goods and services
- Class 005 — Pharmaceuticals: Nutraceuticals for use as a dietary supplement in the management of diabetes risks and symptoms
Owner
- Shenzhen HighTide Biopharmaceutical, Ltd., Shenzhen, CN
- Shenzhen HighTide Biopharmaceutical, Ltd., Shenzhen, CN
- Shenzhen HighTide Biopharmaceutical, Ltd., Shenzhen, CN
Prosecution history
- 01 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Jun 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 May 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Nov 2022 — TEAS SECTION 8 & 15 RECEIVED
- 07 Nov 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 05 Oct 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Oct 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Oct 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Sept 2017 — USE AMENDMENT FILED
- 18 Sept 2017 — TEAS STATEMENT OF USE RECEIVED
- 29 Mar 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2017 — SOU EXTENSION 3 GRANTED
- 27 Mar 2017 — SOU EXTENSION 3 FILED
- 27 Mar 2017 — SOU TEAS EXTENSION RECEIVED